Clinical Trials Logo

Sanfilippo B clinical trials

View clinical trials related to Sanfilippo B.

Filter by:
  • None
  • Page 1

NCT ID: NCT02618512 Terminated - Sanfilippo B Clinical Trials

A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously

CL01-T
Start date: October 15, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluated the safety and tolerability of intravenous (IV) administration of SBC-103 in previously studied, SBC-103 treatment naïve patients with mucopolysaccharidosis III, type B (MPS IIIB, Sanfilippo B) who participated in the NGLU-CL01 study. The NGLU-CL01 study was a non-interventional study that evaluated structural brain abnormalities and blood brain barrier (BBB) integrity by magnetic resonance imaging (MRI) and cerebrospinal fluid/serum albumin index.